Release Date: 23/11/17 11:05 Summary: Chairman & GM Address Price Sensitive: Yes Download Document 390.93KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%